MDS Analytical Technologies expands cellular analysis capabilities

  • Posted on 22 July 2008

MDS Analytical Technologies says it has acquired California-based Blueshift Biotechnologies for $13 million.

The acquisition of Blueshift Biotechnologies, a developer of screening platforms for life sciences research and maker of the IsoCyte benchtop laser scanning cytometer, expands MDS Analytical Technologies' capabilities in cellular analysis.

MDS Analytical Technologies' cellular imaging product line now includes imaging systems and software that provide life sciences and drug discovery researchers with a more complete solution to conduct HCS and HCA.

  • Share this article
  • Got more on this story? Email PharmaAsia